Pancreatic cancer: are more chemotherapy and surgery needed ?
Mené sur 730 patients atteints d'un cancer du pancréas traité par résection, cet essai international de phase III évalue, du point de vue de la survie globale et de la toxicité, l'intérêt d'ajouter la capécitabine à la gemcitabine dans le cadre d'un traitement adjuvant
Most patients diagnosed with pancreatic cancer die from the disease. Although mortality from the most common cancers has declined in the past few decades, the mortality for patients with pancreatic cancer has remained high. On the basis of rising incidence, demographic data, and survival projections, pancreatic cancer is predicted to become the second most deadly cancer in the near future.